A.   Liquid oral solutions

B.   Nasal spray

C.   Oral disintegrating tablets

D.   Subcutaneous infusions

A.   Nausea and Apical pulse of 56 beats per minute

B.   Dry mouth and Hypoactive bowel sounds

C.   Urinary retention and Dry mouth

D.   Urinary retention and Hypoactive bowel sounds

A.   Atropine available for immediate use. Epinephrine available for immediate use. Telemetry monitor on the patient.Blood pressure equipment for frequent monitoring.

B.   Atropine available for immediate use. Epinephrine available for immediate use. Electroencephalogram ready to place. Blood pressure equipment for frequent monitoring.

C.   Atropine available for immediate use. Electroencephalogram ready to place. Telemetry monitor on the patient. Blood pressure equipment for frequent monitoring.

D.   Atropine available for immediate use. Epinephrine available for immediate use. Telemetry monitor on the patient. Electroencephalogram ready to place.

A.   “The medical alert in my health care record should cover me.”

B.   “I will review any over-the-counter medications with my health care provider.”

C.   “I hope to feel improvement in muscle strength.”

D.   “I will take the medication 30 minutes before meals.”

A.   A walking program at least once a week

B.   Limit sleep during the day

C.   Add more stimuli to the environment

D.   Increased responsibility for self-care

A.   Ability to speak clearly

B.   Decreased respiration

C.   Increased arm strength

D.   Ability to swallow without difficulty

A.   Postoperative ischemic colitis

B.   Urinary atony

C.   Postoperative hypotension

D.   Respiratory atelectasis

A.   Donepezil

B.   Rivastigmine

C.   Atropine

D.   Memantine

A.   Dry eye syndrome

B.   Macular degeneration

C.   Glaucoma

D.   Cataracts

A.   Memantine

B.   Tacrine

C.   Carbachol

D.   Physostigmine

A.   Echothiophate

B.   Atropine

C.   Pyridostigmine

D.   Donepezil

A.   Rivastigmine

B.   Neostigmine

C.   Pilocarpine

D.   Succinylcholine

A.   Atropine

B.   Epinephrine

C.   Memantine

D.   Rivastigmine

A.   Bethanechol

B.   Succinylcholine

C.   Cevimeline

D.   Donepezil

A.   Measure the patient’s urinary output.

B.   Administer epinephrine.

C.   Monitor the patient’s heart rate.

D.   Assess the patient’s breath sounds.

A.   Intravenous

B.   Ocular

C.   Oral

D.   Intramuscular

A.   Memantine

B.   Bethanechol

C.   Donepezil

D.   Pyridostigmine

A.   Chronic refractory heartburn

B.   Gastric atony

C.   Hyperthyroidism

D.   Urinary retention

A.   Relaxed muscles

B.   Urination

C.   Increased cognition

D.   Wakefulness

A.   Neostigmine and Galantamine

B.   Galantamine and Edrophonium

C.   Neostigmine and Edrophonium

D.   Pilocarpine and Succinylcholine

A.   Musculoskeletal

B.   Gastrointestinal

C.   Urinary

D.   Neurologic

A.   Dextrose solution intravenously

B.   Physostigmine intravenously

C.   A high dose of donepezil orally

D.   An antihistamine intravenously

A.   Dry cough, Dizziness, Bradycardia, Hypotension

B.   Sweating, Dizziness, Dry cough, Hypotension

C.   Sweating, Dizziness, Bradycardia, Hypotension

D.   Sweating, Dizziness, Bradycardia, Dry cough

A.   Inability to sleep

B.   Respiratory rate 30 breaths/min

C.   Blood pressure 70/40 mm Hg

D.   Raised, erythematous rash

A.   Physostigmine, Donepezil, Memantine

B.   Donepezil, Neostigmine, Memantine

C.   Neostigmine, Pyridostigmine, Physostigmine

D.   Donepezil, Memantine, Pyridostigmine

A.   "You will take this medication once per week."

B.   "Be cautious with activity until you know how the medication affects you."

C.   "Do not drink grapefruit juice while on this medication."

D.   "Do not take this medication with food."

A.   "I can tell my muscle strength has gotten better."

B.   "I have noticed that I have been urinating more frequently."

C.   "I feel like I am coughing up more phlegm."

D.   "My family says that my memory has improved."

A.   Heart rate 30 beats/min

B.   Constipation

C.   Blood pressure 150/95 mm Hg

D.   Respiratory rate 24 breaths/min

A.   Bethanechol

B.   Edrophonium

C.   Memantine

D.   Physostigmine

A.   Take ibuprofen before rising.

B.   Move from a sitting to standing position slowly.

C.   Increase fluid intake to increase blood volume.

D.   Call for someone before rising.

A.   Donepezil

B.   Rivastigmine

C.   Galantamine

D.   Memantine

A.   Vital signs

B.   Blood glucose level

C.   Bowel sounds

D.   Body mass index

A.   "Let me assess what other medications the patient is taking."

B.   "Sometimes family members aren’t the best at assessing these things."

C.   "I will call the health care provider and ask for the medication to be changed."

D.   "The medication has an onset of action of about 3 weeks."

A.   Ataxia, Insomnia, Dyspnea

B.   Ataxia, Dyspnea, Hypotension

C.   Gastrointestinal (GI) upset, Ataxia, Dyspnea

D.   Insomnia, Hypotension, Gastrointestinal (GI) upset

A.   Emphysema, Hypothyroidism

B.   Asthma, Coronary artery disease

C.   Emphysema, Psoriatic arthritis.

D.   Hypothyroidism, Psoriatic arthritis.

A.   "Do not eat solid food."

B.   "Notify your health care provider if you have a headache."

C.   "Take the medication 30 minutes after eating."

D.   "Seek medical help if you develop nausea and vomiting."

A.   Nicotinic-receptor stimulation causes dilation of the pupils. Muscarinic-receptor stimulation causes constriction of blood vessels. Nicotinic-receptor stimulation causes increased blood pressure.

B.   Nicotinic-receptor stimulation causes dilation of the pupils. Muscarinic-receptor stimulation causes constriction of blood vessels. Muscarinic-receptor stimulation causes increased gastrointestinal motility.

C.   Nicotinic-receptor stimulation causes increased contraction of skeletal muscle. Nicotinic-receptor stimulation causes dilation of the pupils. Muscarinic-receptor stimulation causes constriction of blood vessels.

D.   Nicotinic-receptor stimulation causes increased blood pressure. Muscarinic-receptor stimulation causes increased gastrointestinal motility. Nicotinic-receptor stimulation causes increased contraction of skeletal muscle.

A.   Cognitive stabilization for a few months

B.   Gradual decrease in cognitive function

C.   Temporary improvement in cognitive skills

D.   Rapid cognitive changes with decline

A.   5 mg

B.   10 mg

C.   7 mg

D.   2 mg

A.   Orthostatic hypotension, Hypoglycemia, Hypothyroidism

B.   Hypoglycemia, Hypothyroidism, Dyspnea

C.   Bronchoconstriction, Hypoglycemia, Hypothyroidism

D.   Dyspnea, Bronchoconstriction, Orthostatic hypotension

A.   Administer atropine. Provide a high-fiber diet. Administer a stool softener. Ambulate the patient as tolerated. Increase fluid intake as tolerated.

B.   Inject bethanechol. Administer atropine. Administer a stool softener. Ambulate the patient as tolerated. Increase fluid intake as tolerated.

C.   Inject bethanechol. Provide a high-fiber diet. Administer a stool softener. Ambulate the patient as tolerated. Increase fluid intake as tolerated.

D.   Inject bethanechol. Provide a high-fiber diet. Administer a stool softener. Administer atropine. Increase fluid intake as tolerated.

A.   10 mg

B.   12 mg

C.   18 mg

D.   7 mg

A.   "Do not take the medication if you feel tired." "Take the medication on an empty stomach." "Get up slowly from a sitting or lying position."

B.   "Your drug dose will be gradually increased." "Get up slowly from a sitting or lying position." "Tell your health care provider if you have gastric pain that does not subside."

C.   "Do not take the medication if you feel tired." "Take the medication on an empty stomach." "Your drug dose will be gradually increased."

D.   "Tell your health care provider if you have gastric pain that does not subside." "Do not take the medication if you feel tired." "Take the medication on an empty stomach."

A.   An antidote to tricyclic antidepressant toxicity. Relieve severe constriction of the bronchioles. Treat a patient with a prolonged history of sleep deprivation

B.   Relieve severe constriction of the bronchioles. Treat a patient with a prolonged history of sleep deprivation. An antidote in biochemical warfare

C.   Diagnose and treat myasthenia gravis. An antidote in biochemical warfare. An antidote to tricyclic antidepressant toxicity

D.   Relieve severe constriction of the bronchioles. Diagnose and treat myasthenia gravis. Treat a patient with a prolonged history of sleep deprivation

A.   Peptic ulcer and nonobstructive urinary retention

B.   Urinary retention from neurogenic atony of the bladder

C.   Decreased urination with possible renal calculi

D.   Post orthopedic surgery, low urinary output and bronchial wheezing

A.   Get up slowly. Eat something if you feel nauseated. You may have some trouble sleeping. Stop the medication if you have headaches.

B.   Get up slowly. Eat something if you feel nauseated. Stop the medication if you have headaches. Tell your health care provider if you have stomach pains.

C.   Stop the medication if you have headaches. Eat something if you feel nauseated. You may have some trouble sleeping. Tell your health care provider if you have stomach pains.

D.   Get up slowly. Eat something if you feel nauseated. You may have some trouble sleeping. Tell your health care provider if you have stomach pains.

A.   Ataxia and Bleeding

B.   Bleeding and Cramps

C.   Diarrhea and Syncope

D.   Ataxia and Cramps

A.   Neurologic status, Cardiovascular status, Gastrourinary (GU) status, Assess for suicidal tendencies

B.   Pain assessment, Complete blood count, Gastrourinary (GU) status, Assess for suicidal tendencies

C.   Cardiovascular status, Pain assessment, Complete blood count, Neurologic status

D.   Cardiovascular status, Gastrourinary (GU) status, Pain assessment, Complete blood count

A.   Add more stimuli to the environment

B.   A walking program at least once a week

C.   Limit sleep during the day

D.   Increased responsibility for self-care

A.   “The medical alert in my health care record should cover me.”

B.   “I will take the medication 30 minutes before meals.”

C.   “I will review any over-the-counter medications with my health care provider.”

D.   “I hope to feel improvement in muscle strength.”

A.   Decreased heart rate and Increased respiratory secretions

B.   Decreased gastric motility and Pupil dilation

C.   Decreased gastric motility and Decreased sweat gland secretion

D.   Pupil dilation and Decreased sweat gland secretion

A.   Assessment of bowel sounds

B.   Assessment of blood pressure

C.   Administration of a second drug

D.   Administration of another dose in an hour

A.   Hypertension and Syncope

B.   Hair loss and Constipation

C.   Constipation and Mydriasis

D.   Hair loss and Mydriasis

A.   Able to walk long distances

B.   Improved memory

C.   Increased muscle strength

D.   No longer dizzy

A.   Increased muscle strength

B.   Moist oral mucous membranesn

C.   Improved vision

D.   Relief of dry skin

A.   Elevated heart rate

B.   Pupil constriction

C.   Decreased heart rate

D.   Pupil dilation

A.   Lidocaine

B.   Epinephrine

C.   Atropine

D.   Dopamine

A.   "This medication will enhance your memory."

B.   "This medication should cure your Alzheimer’s disease."

C.   "This medication will increase your ability to sleep without dreaming."

D.   "You will only need to take this medication for 3 months."

A.   Hyperthyroidism, Coronary artery disease, Emphysema, Type 2 diabetes mellitus

B.   Peptic ulcer, Parkinsonism, Hyperthyroidism, Coronary artery disease

C.   Emphysema, Type 2 diabetes mellitus, Parkinsonism, Hyperthyroidism,

D.   Emphysema, Type 2 diabetes mellitus, Peptic ulcer, Parkinsonism,

A.   Administer 30 minutes before meals.

B.   Administer after meals.

C.   Administer with fruit juices.

D.   Administer after dissolving in water.